180 Life Sciences Corp. (NASDAQ: ATNF)
$1.5850
+0.0250 ( +1.60% ) 110.1K
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
Market Data
Open
$1.5850
Previous close
$1.5600
Volume
110.1K
Market cap
$5.05M
Day range
$1.4960 - $1.6570
52 week range
$1.1600 - $17.7500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 63 | Aug 12, 2024 |
| 8-k | 8K-related | 15 | Jul 30, 2024 |
| 8-k | 8K-related | 15 | Jul 23, 2024 |
| 8-k | 8K-related | 15 | Jul 02, 2024 |
| 8-k | 8K-related | 14 | May 21, 2024 |
| 8-k | 8K-related | 14 | May 15, 2024 |
| 10-q | Quarterly Reports | 62 | May 15, 2024 |
| 8-k | 8K-related | 20 | May 09, 2024 |
| 10-k/a | Quarterly Reports | 17 | Apr 29, 2024 |
| 8-k | 8K-related | 17 | Apr 19, 2024 |